Clinical Trials on Gestational Diabetes Mellitus in Austria

Total 990 results

University Hospital Tuebingen
Medical University of Vienna; University of Bern; CenTrial GmbH

Terminated

Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine

Obesity | Diabetes

Austria, Germany, Switzerland
Bristol-Myers Squibb

Completed

Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B)

Diabetes

United States
Menzies Institute for Medical Research

Recruiting

Metabolic Benefits of Drinking Blueberry Tea in Type 2 Diabetes

Type 2 Diabetes

Australia
Medingo Ltd

Completed

Feasibility Study of the Solo™ Insulin Pump

Type 1 Diabetes | Insulin Pump Users

Israel, Austria
University of Adelaide
Royal Adelaide Hospital

Completed

Insulin Sensitivity During Hyperbaric Oxygen Compared to Hyperbaric Air (HOTAIR4)

Insulin Resistance | Diabetes Mellitus, Type II

Australia
Medical University of Graz

Completed

Risk Identification of the GlucoTab System in Routine Use

Diabetes Mellitus

Austria
AstraZeneca

Completed

Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered

Type 2 Diabetes Mellitus

United States
Novo Nordisk A/S

Completed

A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes

Austria, Germany, United Kingdom, Sweden, Switzerland
AstraZeneca
Bristol-Myers Squibb

Completed

Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects

Type 2 Diabetes Mellitus

United States
AstraZeneca
Bristol-Myers Squibb

Completed

Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects

Type 2 Diabetes Mellitus

United States
AstraZeneca
Bristol-Myers Squibb

Terminated

Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects

Type 2 Diabetes Mellitus

United States
AstraZeneca

Completed

Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects

Type 2 Diabetes Mellitus

United States
AstraZeneca

Completed

Pharmacokinetics and Pharmacodynamics Study of Saxagliptin in Healthy Subjects

Type 2 Diabetes Mellitus

United States
GlaxoSmithKline

Completed

A Drug Interaction Study Between Simvastatin and GSK376501

Type 2 Diabetes Mellitus

United States
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Not yet recruiting

XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults

Obesity | Type 2 Diabetes Mellitus

Australia
University of Cambridge
Medical University of Graz; University Hospital Inselspital, Berne; Manchester...

Completed

Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions (AP@Home04_P3)

Type 1 Diabetes

United Kingdom, Austria, Switzerland
Avigen

Completed

Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain

Diabetic Neuropathy

Australia
AstraZeneca

Completed

Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants

Type 2 Diabetes Mellitus

United States
Cantonal Hospital of St. Gallen
Medical University of Graz; European Foundation for the Study of Diabetes

Completed

Restoration of Beta Cell Function and Cardiovascular Parameters in Relation to Adipoinsular and Enteroinsular Axes After Gastric Bypass Surgery

Diabetes Mellitus, Type 2 | Bariatric Surgery Candidate

Austria, Switzerland
St Vincent's Institute of Medical Research
Juvenile Diabetes Research Foundation; Juvenile Diabetes Research Foundation...

Active, not recruiting

Baricitinib in New-onset Type 1 Diabetes (BANDIT)

Type 1 Diabetes

Australia
Solvay Pharmaceuticals

Completed

A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes

Patients With Type 2 Diabetes

Australia
DiObex

Terminated

A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes

Type 2 Diabetes

Australia, United States, New Zealand
National Institute of Diabetes and Digestive and...

Completed

Education and Group Support for Diabetic Hispanics

Diabetes Mellitus, Non-Insulin-Dependent

United States
Bristol-Myers Squibb

Completed

Safety Study of BMS-816336 in Healthy Male Subjects

Dyslipidemia | Diabetes Mellitus, Non-Insulin-Dependent

Australia
Melbourne Health
National Health and Medical Research Council, Australia; Juvenile Diabetes...

Active, not recruiting

Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes (IAA)

Diabetes Mellitus, Type 1 | Type 1 Diabetes

Australia
MetaCure (USA), Inc.

Completed

The TANTALUS® II for the Treatment of Type 2 Diabetes (Crossover)

Diabetes Mellitus, Type 2

Austria, Germany, Italy, Poland
Hunter and New England Health

Completed

Dealing With Anxiety: A Cognitive Behavioural Program for Diabetes

Diabetes Mellitus Type 2

Australia
Menzies School of Health Research

Withdrawn

Medication in Early Diabetes (MED) Study

Diabetes Mellitus, Type 2

Australia
St Vincent's Hospital Melbourne
Juvenile Diabetes Research Foundation; Medtronic

Completed

The Performance of an Artificial Pancreas at Home in People With Type 1 Diabetes

Type 1 Diabetes

Australia
Medical University of Graz

Recruiting

Diabetes Registry Graz for Biomarker Research (GIRO)

Type1diabetes | Type 2 Diabetes | Adiposity

Austria
Cynata Therapeutics Limited

Active, not recruiting

Safety, Tolerability and Efficacy of CYP-006TK in Adults With Diabetic Foot Ulcers

Diabetic Foot Ulcer | Cutaneous Ulcer

Australia
Texas Diabetes & Endocrinology, P.A.

Completed

FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump

Type 1 Diabetes Mellitus

United States
Medical University of Vienna

Completed

Correlation of Flicker Induced and Flow Mediated Vasodilatation in Patients With Endothelial Dysfunction and Healthy Volunteers.

Hypertension | Diabetes Mellitus, Type 1 | Hypercholesterolemia | Regional Blood Flow

Austria
Melbourne Health

Completed

Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes (INITII)

Type 1 Diabetes

Australia, New Zealand
AstraZeneca
Eli Lilly and Company

Completed

An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Italy, Korea, Republic of, Hungary, Canada, Australia
DiObex

Terminated

Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients

Type 2 Diabetes

Australia, United States, New Zealand
University of Texas at Austin

Recruiting

Resilience-Based Diabetes Self-Management Education (RB-DSME) for African Americans (TXSTRIDE)

Type 2 Diabetes

United States
Northern Sydney and Central Coast Area Health Service

Enrolling by invitation

Transition of Care in Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus | Transition

Australia
Bayside Health
Baker Heart Research Institute; International Diabetes Institute, Australia

Terminated

Type 2 Diabetes and Exercise - A Pilot Study

Type 2 Diabetes

Australia
Gold Coast Hospital and Health Service
University of Canberra

Completed

Low Carbohydrate Diet, Glycaemic Control and Quality of Life in Australian Adults With Type 1 Diabetes

Type 1 Diabetes Mellitus

Australia
Bayer

Completed

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN)

Diabetic Nephropathies

Hong Kong, Australia, Spain, Portugal, United States, France, Canada, Netherlands, Austria, Finland, Poland, Taiwan, Hungary, Israel, Italy, South Africa, Sweden, Bulgaria, Germany, Denmark, Czechia, Korea, Republic of, Norway
The George Institute

Not yet recruiting

Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis (BEST-DKA)

Diabetic Ketoacidosis

Australia
Boehringer Ingelheim

Completed

A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment (PARTRIDGE)

Diabetic Retinopathy

Spain, United Kingdom, United States, Netherlands, Australia, Latvia
University of Sydney

Completed

The Effect of a Nutritional Supplement in Individuals With Type 2 Diabetes Mellitus: a Pilot Study

Diabetes Mellitus, Type 2 | Insulin Resistance

Australia
DyaMX Inc.

Active, not recruiting

Safety and Feasibility of a Novel Endoscopic Intervention for the Treatment of Type II Diabetes (REGENT-1)

Type 2 Diabetes

Australia
University of Texas at Austin

Completed

Cognitive Training for Diabetes Self-Management

Diabetes Mellitus, Type 2

United States
Seton Healthcare Family
Cancer Prevention Research Institute of Texas

Completed

Sequencing T-cells in Type I Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Novo Nordisk A/S

Completed

Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers

Diabetes Mellitus, Type 2 | Diabetes

United States
Novo Nordisk A/S

Completed

Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function

Diabetes Mellitus, Type 2 | Diabetes

Australia
Austin Health

Completed

Reandron in Diabetic Men Witn Low Testosterone Level

Type 2 Diabetes | Hypogonadism

Australia

Clinical Trials on Gestational Diabetes Mellitus in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations